| Product Name | MF | CAS | Details |
|---|
| N-Fmoc-N-propyl-glycine | C20H21NO4 | 1310680-42-2 | Details |
| 2,5,2'-Trihydroxy-4-methoxybenzophenone | C14H12O5 | 202463-52-3 | Details |
| H-KRQDILDLWVY-OH | Details |
| 1-(Chloromethyl)-2-fluoro-3-(trifluoromethyl)benzene | C8H5ClF4 | 1214366-56-9 | Details |
| 4-Oxo valsartan benzyl ester | C31H33N5O4 | 188240-32-6 | Details |
| Rabbit anti-Human IgG4 Antibody | Details |
| 2-[(Thiophen-2-ylmethyl)sulfanyl]benzoic acid | C12H10O2S2 | 3759-75-9 | Details |
| Ethyl 6,6-dimethyl-2,4-dioxopiperidine-3-carboxylate | C10H15NO4 | 845267-64-3 | Details |
| 3-Amino-5-methylbenzene-1-sulfonamide | C7H10N2O2S | 1017448-52-0 | Details |
| Methyl 3-methylimidazo[1,5-a]pyridine-6-carboxylate | C10H10N2O2 | 1803611-30-4 | Details |
| 3,4-dihydro-1,6-naphthyridin-2(1h)-one | C8H8N2O | 14757-41-6 | Details |
| 1-b-D-Ribofuranosyl-1,2,4-triazole-3-carboxylic acid methyl ester | C9H13N3O6 | 38934-69-9 | Details |
| Cyclobutylmethyl chloroformate | C6H9ClO2 | 81228-88-8 | Details |
| Claudin 23 antibody | Details |
| 5-bromo-3-nitrobenzene-1,2-diol | C6H4BrNO4 | 671779-99-0 | Details |
| N-(2-Methoxyphenyl)-2-(piperazin-1-yl)acetamide hydrochloride | C13H20ClN3O2 | 1158358-15-6 | Details |
| 1,2-Distearoyl-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 | 326495-36-7 | Details |
| HHAT Blocking Peptide | Details |
| 1-(3-Chlorophenyl)-3-methyl-4,5-dihydro-1H-pyrazol-5-one | C10H9ClN2O | 90-31-3 | Details |
| H-Ile-Val-OH | C11H22N2O3 | 41017-96-3 | Details |
| 2-[4-(Chloromethyl)-1,3-thiazol-2-yl]pyridine | C9H7ClN2S | 342025-41-6 | Details |
| 4-(2-Bromophenyl)oxane-4-carbonitrile | C12H12BrNO | 1368722-46-6 | Details |
| Moexipril-d5 | C27H29D5N2O7 | 1356929-49-1 | Details |
| N-Hippuryl-His-Leu trifluroacetate hydrate | C21H31N5O5 | 207386-83-2 | Details |
| Mogroside II-?A | C42H72O14 | 1613527-65-3 | Details |
| 3,4-Dimethylcinnamic acid | C11H12O2 | 60521-25-7 | Details |
| Tradipitant | C28H16ClF6N5O | 622370-35-8 | Details |
| 2-(1-Acetylpiperidin-2-yl)acetic acid | C9H15NO3 | 25393-20-8 | Details |
| BTRX-335140 | C25H32FN5O2 | 2244614-14-8 | Details |
| H-NQAEEELIK-OH | Details |
| Methyl 3-(4-bromophenyl)prop-2-ynoate | C10H7BrO2 | 42122-27-0 | Details |
| 3-Methoxy-alpha-Methyl-L-Tyrosine | C11H15NO4 | 6739-31-7 | Details |
| 1-(1,3-Benzodioxol-5-yl)cyclopropanecarbonitrile | C11H9NO2 | 33522-14-4 | Details |
| ATG3 Blocking Peptide | Details |
| 6-Carboxyfluoresceine diacetate | C25H16O9 | 3348-03-6 | Details |
| PLRG1 antibody | Details |
| 4,4'-Dipyridyl - 98% | C10H8N2 | 553-26-4 | Details |
| 1-Propylpyrrolidine-2-carboxylic acid | C8H15NO2 | 101253-30-9 | Details |
| VP 14637 | C25H22N10O3 | 235106-62-4 | Details |
| Poly(propylene glycol) diglycidyl ether, Mn~380 | (C3H6O)n.C6H10O3 | 26142-30-3 | Details |
| Human BAFF ELISA Kit | Details |
| COL6A1 antibody | Details |
| 4-(Difluoromethyl)-6-(furan-2-yl)-2-(piperazin-1-yl)pyrimidine | C13H14F2N4O | 861438-09-7 | Details |
| WX 671 | C32H47N5O6S | 590368-25-5 | Details |
| 2-(1-Methylazetidin-3-yl)ethan-1-amine | C6H14N2 | 1542210-23-0 | Details |
| 4-Chloro-5-ethyl-7H-pyrrolo[2,3-d]pyrimidine | C8H8ClN3 | 1004992-44-2 | Details |
| N6-Benzyl-5'-ethylcarboxamidoadenosine | C19H22N6O4 | 152918-32-6 | Details |
| 4-(3-Oxo-2,3-dihydro-1,2-benzothiazol-2-yl)butanoic acid | C11H11NO3S | 89139-50-4 | Details |
| RNPEP antibody | Details |
| N-[1-(Propan-2-yl)piperidin-4-ylidene]hydroxylamine | C8H16N2O | 832741-00-1 | Details |
| Chasmanine | C25H41NO6 | 5066-78-4 | Details |
| H-KSYVLEGTLTAEK-OH | Details |
| Man-9 Glycan, 2-AB labelled | Details |
| 2,3,6,2',3',4',6'-Hepta-O-acetyl-b-lactosyl azide | C26H35N3O17 | 30854-62-7 | Details |
| Zomepirac-acyl-b-D-glucuronide | C21H22ClNO9 | 75871-31-7 | Details |
| 1-(4-Methylpyridin-2-yl)-1H-pyrazol-5-amine | C9H10N4 | 1250693-08-3 | Details |
| Annexin A1 Heavy | Details |
| [5-[(Dimethylamino)methyl]furan-2-yl]methanol | C8H13NO2 | 15433-79-1 | Details |
| 4-Bromo-1-(2-nitrophenyl)-1H-pyrazole | C9H6BrN3O2 | 957034-96-7 | Details |
| 3-Methoxy-4-(thiophen-2-ylmethoxy)benzaldehyde | C13H12O3S | 838882-69-2 | Details |
| 3-(Propan-2-yl)-2,3-dihydro-1H-inden-1-ol | C12H16O | 1820580-05-9 | Details |
| 2',5,6',7-Tetrahydroxyflavone | C15H10O6 | 82475-00-1 | Details |
| SLC27A6 Blocking Peptide | Details |
| (2-(4-methoxyphenyl)-1-oxo-3-(3-pyridyl)(4-2,3,4-trihydroisoquinolyl))-N-(4-pyridylmethyl)formamide | C28H24N4O3 | 1022744-73-5 | Details |
| ARL6IP6 antibody | Details |
| H-Phe-Phe-Phe-Phe-OH | C36H38N4O5 | 2667-02-9 | Details |
| 1-[(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]piperidin-3-amine | C11H18N4O | 1249245-86-0 | Details |
| N-[2-(Aziridin-1-yl)ethyl]-2-[(2,4-dimethylphenyl)sulfanyl]aniline | C18H22N2S | 1928741-86-9 | Details |
| N-(2-Chlorobenzyl)cyclopropanamine hydrochloride | C10H13Cl2N | 1184999-03-8 | Details |
| 2-[2-Methyl-4-(thiophen-2-yl)-1,3-thiazol-5-yl]acetic acid | C10H9NO2S2 | 314032-13-8 | Details |
| Recombinant Human CD30 | Details |
| rac-Ethyl (1R,4Z,8S)-8-aminocyclooct-4-ene-1-carboxylate hydrochloride | 350015-73-5 | Details |
| [3-(3-chlorophenyl)propyl]amine | C9H12ClN | 18655-49-7 | Details |
| 5-Cyclopentylpiperidine-2-carboxylic acids | C11H19NO2 | 2137443-01-5 | Details |
| AKAP8L antibody | Details |
| 1-Bromo-4-ethynyl-2-methoxybenzene | C9H7BrO | 69151-17-3 | Details |
| H-AHYDLR^-OH | Details |
| 2,3-Diiodopyrazine | C4H2I2N2 | 58139-07-4 | Details |
| CDS2 antibody | Details |
| 5-Methyl-1-[(2-methylphenyl)methyl]-1H-pyrazol-3-amine | C12H15N3 | 956393-77-4 | Details |
| N-amino-2-(3,5-dimethylphenoxy)propanamide | C11H16N2O2 | 587652-62-8 | Details |
| 17:0-20:4 Pi (3,4) P2 | C46H86NO19P3 | 1144099-87-5 | Details |
| 2,3-Dihydro-1H-pyrrolizine-7-carboxylic acid | C8H9NO2 | 116515-48-1 | Details |
| 4-[8-[(2,6-Diethoxy-4′-fluoro[1,1′-biphenyl]-4-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]dec-2-yl]benzoic acid hydrochloride | Details |
| 4,4-dimethyl-3,5-dioxa-8-azatricyclo[5.2.1.02,?]decan-9-one | C9H13NO3 | 116856-49-6 | Details |
| 2-Methyl-3-(4-methylpiperidin-1-yl)propanehydrazide | C10H21N3O | 744243-56-9 | Details |
| 2-Phenyl-2-(1H-pyrazol-1-yl)acetic acid | C11H10N2O2 | 87581-64-4 | Details |
| tert-Butyl 3-diazo-2-oxopropanoate | 71901-63-8 | Details |
| Acid brown 97 | 61901-18-6 | Details |
| (2S)-1,1,1-Trifluoro-3,3-dimethylbutan-2-amine hydrochloride | C6H13ClF3N | 336105-51-2 | Details |
| LCB-2853 | C21H24ClNO4S | 141335-10-6 | Details |
| 5-(4-Methoxyphenyl)-4-(2-phenylethyl)-4H-1,2,4-triazole-3-thiol | C17H17N3OS | 221325-22-0 | Details |
| 5,6,7,8-Tetrahydronaphthalen-2-yl chloroformate | C11H11ClO2 | 1506544-79-1 | Details |
| Ravulizumab | 1803171-55-2 | Details |
| 4-Deoxythreonic acid | C4H8O4 | 5057-93-2 | Details |
| PGM1 antibody | Details |
| (1-[(4-Iodophenyl)methyl]piperidin-3-yl)methanol | C13H18INO | 1423897-10-2 | Details |
| 1-[2-(4-Fluorophenyl)ethyl]piperazine hydrochloride | C12H18ClFN2 | 349663-44-1 | Details |
| Recombinant Rat CXCL7 | Details |
| 3-[3-(Benzyloxy)phenyl]-2-(thiophen-2-yl)prop-2-enoic acid | C20H16O3S | 852851-88-8 | Details |
| Product Total： Product Page： | ||||
| 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 | ||||